Dyne Therapeutics, Inc. ($DYN)
Filing Information
| Accession Number | 0001193125-26-281119 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 24, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
263,962
Total Value
$5,464,611.43
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jun 22, 2026 | Sale | 190,676 | $20.57 | $3,922,262.52 | 3,921,542 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jun 23, 2026 | Sale | 71,629 | $21.04 | $1,506,766.16 | 3,849,913 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jun 23, 2026 | Sale | 1,657 | $21.47 | $35,582.75 | 3,848,256 | Indirect | See footnote | View Details |